Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis
Background: A large proportion of patients with inflammatory bowel disease (IBD) relapse after drug discontinuation despite achieving a stable state of infliximab-induced clinical remission. Resuming the use of the same tumor necrosis factor-alpha (TNF-α) inhibitors in patients who relapse following...
Saved in:
Main Authors: | Seungwon Yang (Author), Siyoung Yang (Author), Young Kwon Jo (Author), Seungyeon Kim (Author), Min Jung Chang (Author), Junjeong Choi (Author), Jae Hee Cheon (Author), Yun Mi Yu (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Infliximab in inflammatory bowel disease
by: Konstantinos Papamichael, et al.
Published: (2019) -
USE OF INFLIXIMAB IN THE CASE OF INFLAMMATORY BOWEL DISEASE IN CHILDREN
by: N.E. Shchigoleva, et al.
Published: (2010) -
USE OF INFLIXIMAB IN THE CASE OF INFLAMMATORY BOWEL DISEASE IN CHILDREN
by: N.E. Shchigoleva, et al.
Published: (2010) -
Infusion Reactions to Infliximab in Pediatric Patients with Inflammatory Bowel Disease
by: Rajmohan Dharmaraj, et al.
Published: (2024) -
Advances in the Endoscopic Assessment of Inflammatory Bowel Diseases: Cooperation between Endoscopic and Pathologic Evaluations
by: Jae Hee Cheon
Published: (2015)